Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 CAD | +4.94% | +0.59% | -49.25% |
Sales 2024 * | - | Sales 2025 * | 1.04M 762K 61.05M | Capitalization | 26.72M 19.53M 1.56B |
---|---|---|---|---|---|
Net income 2024 * | -74M -54.09M -4.33B | Net income 2025 * | -54M -39.47M -3.16B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 25.6 x |
P/E ratio 2024 * |
-0.24
x | P/E ratio 2025 * |
-0.35
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.29% |
Latest transcript on Aptose Biosciences Inc.
1 day | +4.94% | ||
1 week | +0.59% | ||
Current month | -24.11% | ||
1 month | -17.07% | ||
3 months | -35.61% | ||
6 months | -62.05% | ||
Current year | -49.25% |
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 27/10/13 |
C. Payne
DFI | Director of Finance/CFO | 61 | 26/06/22 |
Chief Tech/Sci/R&D Officer | - | 31/10/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 18/09/07 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 12/09/22 |
Mark Vincent
BRD | Director/Board Member | 71 | 18/09/07 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.7 | +4.94% | 34,400 |
25/04/24 | 1.62 | -2.41% | 13,330 |
24/04/24 | 1.66 | +0.61% | 10,087 |
23/04/24 | 1.65 | -2.94% | 8,444 |
22/04/24 | 1.7 | +0.59% | 601 |
Delayed Quote Toronto S.E., April 26, 2024 at 08:59 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.25% | 19.52M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- APS Stock